This Article Full Text Full Text (PDF) All Versions of this Article: 2002-0217OCv1 29/6/721    most recent Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Weissmann, N. Articles by Grimminger, F. Search for Related Content PubMed PubMed Citation Articles by Weissmann, N. Articles by Grimminger, F.

Effects of Mitochondrial Inhibitors and Uncouplers on Hypoxic Vasoconstriction in Rabbit Lungs

Department of Internal Medicine, Justus-Liebig University Giessen, Giessen, Germany

Address correspondence to: Norbert Weissmann, Ph.D., Department of Internal Medicine, Justus-Liebig-University Giessen, Klinikstrasse 36, 35392 Giessen, Germany. E-mail: Norbert.Weissmann{at}innere.med.uni-giessen.de

Hypoxic pulmonary vasoconstriction (HPV) matches lung perfusion to ventilation for optimizing pulmonary gas exchange; however, the underlying mechanism has not yet been fully elucidated. Lung nitric oxide (NO) generation appears to be involved in this process. Recently, mitochondria have been proposed as oxygen sensors, with HPV signaling via a hypoxia-induced increase in the generation of reactive oxygen species derived from mitochondrial complex III and escaping through an anion channel into the cytoplasm. In addition, complex II has been suggested to be specifically involved in hypoxia-dependent generation of reactive oxygen species in the lung. We investigated the effects of several mitochondrial inhibitors and uncouplers on the strength of HPV, and asked for their capacity to mimic HPV during normoxia in isolated buffer-perfused rabbit lungs. Specificity of the agents for HPV was tested by comparison of their effects on non–hypoxia-induced vasoconstriction, elicited by the thromboxane mimetic U46619. Interference with NO metabolism was determined by performing parallel studies with blocked lung NO generation and by measurement of exhaled NO. Rotenone, 3-nitroproprionic acid, and myxothiazol dose-dependently inhibited HPV without being mimics of HPV during normoxia. The inhibitory effect of these agents was only partly specific for HPV by comparison with U46619-induced vasoconstriction. During pre-blocked lung NO synthesis, the selectivity for HPV inhibition was increased for rotenone, but largely lost for myxothiazol. 2-tenoyltrifluoroacetone resulted in an unspecific inhibition of HPV as compared with U46619-induced vasoconstriction. 1-methyl-4-phenylpyridinium iodide and 2-heptyl-4-hydroxyquinoline-N-oxide specifically suppressed HPV and increased normoxic vascular tone. Antimycin A suppressed HPV, an effect being specific in lungs with intact NO synthesis and only partly specific while blocking NO. However, this agent did not mimic HPV during normoxia, as may be expected for interference with the mitochondrial electron transport downstream in complex III. The uncouplers 2,4-dinitrophenol (DNP, 10–200 µM) and carbonyl cyanide 4-(trifluoromethoxy)phenylhydrazone (FCCP, 1–3 µM) induced sustained vasoconstriction during normoxia, with enhancement of HPV by DNP at low and suppression of HPV for both agents at high concentrations. The anion channel blocker 4,4'-diisothiocyanatostilbene-2,2'-disulfonic acid inhibited HPV and U46619-induced vasoconstriction with identical dose–response curves. These findings suggest that mitochondria are in some manner involved in the regulation of HPV in intact rabbit lungs. The hypothesis that enhanced superoxide leak at complex III of mitochondria represents the underlying mechanism of acute HPV is supported by the rotenone and 2-heptyl-4-hydroxyquinoline-N-oxide data, but partly contradicted by the findings with 1-methyl-4-phenylpyridinium iodide, antimycin A, DNP, and FCCP. Further studies are mandatory to clarify the link between mitochondrial respiratory chain and hypoxic pulmonary vasoconstriction.

Abbreviations: carbonyl cyanide 4-(trifluoromethoxy)phenylhydrazone, FCCP • 4,4'-diisothiocyanatostilbene-2,2'-disulfonic acid, DIDS • 2,4-dinitrophenol, DNP • 2-heptyl-4-hydroxyquinoline N-oxide, HQNO • pulmonary artery pressure difference, PAP • hypoxic pulmonary vasoconstriction, HPV • N^G-monomethyl-L-arginine, L-NMMA • 1-methyl-4-phenylpyridinium iodide, MPP⁺ • pulmonary artery pressure, PAP • 2-tenoyltrifluoroacetone, TTFA • 3-nitroproprionic acid, 3-NPA

This article has been cited by other articles:

				N. Sommer, A. Dietrich, R. T. Schermuly, H. A. Ghofrani, T. Gudermann, R. Schulz, W. Seeger, F. Grimminger, and N. Weissmann Regulation of hypoxic pulmonary vasoconstriction: basic mechanisms Eur. Respir. J., December 1, 2008; 32(6): 1639 - 1651. [Abstract] [Full Text] [PDF]

				G. B. Waypa and P. T. Schumacker Oxygen sensing in hypoxic pulmonary vasoconstriction: using new tools to answer an age-old question Exp Physiol, January 1, 2008; 93(1): 133 - 138. [Abstract] [Full Text] [PDF]

				F. J. Miller Jr, M. Filali, G. J. Huss, B. Stanic, A. Chamseddine, T. J. Barna, and F. S. Lamb Cytokine Activation of Nuclear Factor {kappa}B in Vascular Smooth Muscle Cells Requires Signaling Endosomes Containing Nox1 and ClC-3 Circ. Res., September 28, 2007; 101(7): 663 - 671. [Abstract] [Full Text] [PDF]

				D. L. Hoffman, J. D. Salter, and P. S. Brookes Response of mitochondrial reactive oxygen species generation to steady-state oxygen tension: implications for hypoxic cell signaling Am J Physiol Heart Circ Physiol, January 1, 2007; 292(1): H101 - H108. [Abstract] [Full Text] [PDF]

				G. B. Waypa, R. Guzy, P. T. Mungai, M. M. Mack, J. D. Marks, M. W. Roe, and P. T. Schumacker Increases in Mitochondrial Reactive Oxygen Species Trigger Hypoxia-Induced Calcium Responses in Pulmonary Artery Smooth Muscle Cells Circ. Res., October 27, 2006; 99(9): 970 - 978. [Abstract] [Full Text] [PDF]

				J. P. T. Ward Point:Counterpoint: Hypoxic pulmonary vasoconstriction is/is not mediated by increased production of reactive oxygen species J Appl Physiol, September 1, 2006; 101(3): 993 - 995. [Full Text] [PDF]

				N. Weissmann, N. Sommer, R. T. Schermuly, H. A. Ghofrani, W. Seeger, and F. Grimminger Oxygen sensors in hypoxic pulmonary vasoconstriction Cardiovasc Res, September 1, 2006; 71(4): 620 - 629. [Abstract] [Full Text] [PDF]

				T. A. Sarafian, N. Habib, M. Oldham, N. Seeram, R.-P. Lee, L. Lin, D. P. Tashkin, and M. D. Roth Inhaled marijuana smoke disrupts mitochondrial energetics in pulmonary epithelial cells in vivo Am J Physiol Lung Cell Mol Physiol, June 1, 2006; 290(6): L1202 - L1209. [Abstract] [Full Text] [PDF]

				N. Weissmann, S. Zeller, R. U. Schafer, C. Turowski, M. Ay, K. Quanz, H. A. Ghofrani, R. T. Schermuly, L. Fink, W. Seeger, et al. Impact of Mitochondria and NADPH Oxidases on Acute and Sustained Hypoxic Pulmonary Vasoconstriction Am. J. Respir. Cell Mol. Biol., April 1, 2006; 34(4): 505 - 513. [Abstract] [Full Text] [PDF]

				J. Q. Liu, I. N. Zelko, E. M. Erbynn, J. S. K. Sham, and R. J. Folz Hypoxic pulmonary hypertension: role of superoxide and NADPH oxidase (gp91phox) Am J Physiol Lung Cell Mol Physiol, January 1, 2006; 290(1): L2 - L10. [Abstract] [Full Text] [PDF]

				G. B. Waypa and P. T. Schumacker Hypoxic pulmonary vasoconstriction: redox events in oxygen sensing J Appl Physiol, January 1, 2005; 98(1): 404 - 414. [Abstract] [Full Text] [PDF]